Bicillin L-A Recall

King Pharmaceuticals, a subsidiary of Pfizer, has issued a voluntary recall of some lots of Bicillin L-A distributed between December 11, 2023 and June 24, 2025. The recall is related to particulates in the syringes.

To date, Pfizer reports that no adverse effects have been documented, but Bicillin L-A doses included in the recall should not be used.

Pfizer has issued important instructions on how to identify impacted lots, how to return them, and how to receive reimbursement. Details about the recall, impacted lots, and instructions for customers are accessible in the links below to the recall notice and customer letter:

• Bicillin L-A Recall Letter
• Bicillin L-A Customer Letter and Medical Request Process Information